Evidence map›Paper›PMID 30323356›Full record

ArticleScientific reports2018

Fine-tuning carbapenem resistance by reducing porin permeability of bacteria activated in the selection process of conjugation.

Hoi-Kuan Kong, Qing Pan, Wai-U Lo, Xuan Liu, Carmen O K Law, Ting-Fung Chan, Pak-Leung Ho, Terrence Chi-Kong Lau

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Resolving competing evolutionary histories in joint ancestral state reconstruction.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. ESBL-ProducingMicroorganisms · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Carbapenem-ResistantMedicina (Kaunas, Lithuania) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CREProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hoi-Kuan KongDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.
Qing PanDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.
Wai-U LoDepartment of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.
Xuan LiuDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.
Carmen O K LawDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.
Ting-Fung ChanSchool of Life Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.ORCID http://orcid.org/0000-0002-0489-3884
Pak-Leung HoDepartment of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China.
Terrence Chi-Kong LauDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, Kowloon Tong, People's Republic of China. chiklau@cityu.edu.hk.ORCID http://orcid.org/0000-0002-7505-7306
City University of Hong Kong · HKUniversity of Hong Kong · HKChinese University of Hong Kong · HK

Funding

Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF) 12111662Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF) 1514032Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF) 15140342Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF) HKM-15-M10
6 · The paper itself

Abstract

Antibiotic resistance is an emerging public health issue. Plasmids are one of the popular carriers to disseminate resistance genes among pathogens. However, the response of plasmid-carrying bacteria to antibiotic treatment and how these bacteria evolve to increase their resistance remain elusive. In this study, we conjugated plasmid pNDM-HK to E. coli J53 recipient cells and selected survivors using different concentrations of the broad spectrum antibiotic meropenem. After selection, transconjugants conferred varying minimum inhibitory concentrations with respect to carbapenems. We sequenced and compared the transcriptomes of transconjugants that exhibited distinct carbapenem susceptibilities, and found that the loss of outer membrane proteins led to antibiotic resistance. Moreover, we identified a novel mutation, G63S, in transcription factor OmpR which moderates the expression of outer membrane proteins. The loss of porins was due to incapability of phosphorylation, which is essential for porin transcription and carbapenem resistance. We also characterized other genes that are regulated by ompR in this mutant, which contributed to bacterial antibiotic resistance. Overall, our studies suggest antibiotic pressure after conjugation might be an alternative pathway to promote antimicrobial resistance.

Indexed as

Bacterial ProteinsCarbapenemsConjugation, GeneticDrug Resistance, BacterialEscherichia coliOrganisms, Genetically ModifiedPermeabilityPorinsSelection, GeneticTrans-ActivatorsBacterial ProteinsCarbapenemsosmolarity response regulator proteinsPorinsTrans-Activators

Identifiers

PMID30323356
PMCPMC6189183
OpenAlexW2896892559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.